11 March 2021
The MTPConnect WA Life Sciences Innovation Hub is hosting the next MTP Sector Spotlight Series event in Perth on Wednesday, 31 March, and will shine a light on Artrya, a WA-based digital health start-up aiming to solve heart disease.
MTPConnect’s Director Stakeholder Engagement WA Dr Tracey Wilkinson will be joined by presentations from Artrya’s Co-Founder and Chief Executive Officer John Konstantopoulos and Co-Founder and Executive Chairman John Barrington AM, where they will discuss their mission to solve the world’s largest cause of death - heart disease, engaging with Australia’s regulatory framework and raising investment in WA.
The team at Artrya are using Artificial Intelligence has developed an AI solution to more accurately identify patients at risk of Coronary Artery Disease (CAD) and to guide clinicians in delivering more effective treatment. Their solution provides a consistent, highly accurate diagnosis of heart disease risk in less than two minutes and received Class 1 TGA registration in November 2020. The company was awarded $1 million funding in Round 3 of the BioMedTech Horizons (BMTH) Program, an initiative of the Medical Research Future Fund operated by MTPConnect.
John Konstantopoulos has more than 20 years of commercial and technical experience providing strategic advice to industries such as electronics, healthcare and industrial. He has advised senior executives of some of the worlds and Australia’s largest corporations on product commercialisation, development and digital transformation and has driven growth in markets such as Asia, US and Europe. John Barrington AM is an acknowledged leader in strategy and innovation. He has advised Boards & CEOs of some of Australia’s leading organisations on growth strategies, founded technology innovation companies and facilitated more than 1,000 strategy workshops over 20 years with boards & executive teams.
The event runs from 7:30am – 9am AWST at the Harry Perkins Institute for Medical Research in Perth.
We hope you can join us, register today.